ストックスクリーナーアプリを入手
1.2676
0.19%
-0.0024
前日終値:
$1.27
開ける：
$1.23
24時間の取引高:
23,695
Relative Volume:
0.59
時価総額：
$28.81M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+12.18%
1か月 パフォーマンス:
-13.18%
6か月 パフォーマンス:
-41.59%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.23
$1.28
1週間の範囲:
$1.06
$1.30
52週間の値動き範囲:
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
RNTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.25 | 26.04M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.30 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.51 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
693.50 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
315.31 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2017-07-24 | 開始されました | BofA/Merrill | Buy |
| 2017-07-24 | 開始されました | Jefferies | Buy |
| 2017-07-24 | 開始されました | William Blair | Outperform |
Rein Therapeutics Inc (RNTX) 最新ニュース
Is Rein Therapeutics Inc. stock reversal real or fakeQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Is Rein Therapeutics Inc. Forming a Bottom PatternJuly 2025 Earnings & Weekly Top Stock Performers List - kangso.co.kr
Market reaction to Rein Therapeutics Inc.’s recent news2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Rein Therapeutics Inc. stock daily chart insightsJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
What the charts say about Rein Therapeutics Inc. today2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Rein Therapeutics (NASDAQ:RNTX) Given “Hold” Rating at Brookline Capital Management - Defense World
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - GlobeNewswire
UK regulator approves Rein Therapeutics’ phase 2 trial for IPF drug - Investing.com Canada
Identifying reversal signals in Rein Therapeutics Inc.Market Activity Summary & Real-Time Sentiment Analysis - Newser
Rein Therapeutics' Strategic Path Forward: Navigating Clinical and Funding Challenges in a High-Stakes Biotech Landscape - AInvest
Rein Therapeutics Shares Lower After Brookline Capital Downgrade - MarketScreener
Order flow analysis tools used on Rein Therapeutics Inc.July 2025 Intraday Action & Daily Oversold Bounce Ideas - Newser
Multi factor analysis applied to Rein Therapeutics Inc.CEO Change & Weekly Watchlist for Hot Stocks - Newser
Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders - 富途牛牛
Combining price and volume data for Rein Therapeutics Inc.July 2025 Intraday Action & Community Trade Idea Sharing - Newser
Brookline Capital Downgrades Rein Therapeutics to Hold From Buy - MarketScreener
Using RSI to spot recovery in Rein Therapeutics Inc.Price Action & Daily Oversold Stock Bounce Ideas - Newser
Rein Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Action & AI Enhanced Trading Signals - Newser
Published on: 2025-08-19 03:47:21 - Newser
Is Rein Therapeutics Inc. forming a reversal patternGap Down & Entry and Exit Point Strategies - Newser
What to expect from Rein Therapeutics Inc. in the next 30 daysJuly 2025 Gainers & Precise Buy Zone Identification - Newser
Heatmap analysis for Rein Therapeutics Inc. and competitorsShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Chart based exit strategy for Rein Therapeutics Inc.Quarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Top chart patterns to watch in Rein Therapeutics Inc.2025 Trading Recap & AI Forecasted Entry/Exit Points - Newser
Published on: 2025-08-17 16:12:16 - Newser
What technical models suggest about Rein Therapeutics Inc.’s comebackRate Hike & Consistent Income Trade Ideas - Newser
Is Rein Therapeutics Inc. a Top Dividend Stock to Watch in 2025July 2025 Reactions & Technical Pattern Recognition Alerts - metal.it
Intraday pattern recognizer results for Rein Therapeutics Inc.Quarterly Trade Summary & Real-Time Sentiment Analysis - Newser
What makes Rein Therapeutics Inc. stock price move sharply2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Fibonacci Support Holding Strong in Rein Therapeutics Inc.July 2025 Pullbacks & Risk Controlled Swing Alerts - 선데이타임즈
Earnings visualization tools for Rein Therapeutics Inc.2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
How sentiment analysis helps forecast Rein Therapeutics Inc.M&A Rumor & Risk Managed Investment Entry Signals - Newser
Rein Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025 - GlobeNewswire
Rein Therapeutics Inc (RNTX) 財務データ
Rein Therapeutics Inc (RNTX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.39%
0.57%
大文字化:
|
ボリューム (24 時間):